One appears to strengthen the interaction between T cells and cancer cells, helping the immune system mount a more effective attack. The other makes tumor cells more susceptible to destruction by T cells without directly altering the immune cells themselves. One strengthens the interaction between T cells and cancer cells. The other makes tumor cells more vulnerable to T cells without altering the immune cells. What can melanoma patients do now?